Marshall Fordyce - Nov 16, 2022 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
President and CEO, Director
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Stock symbol
VERA
Transactions as of
Nov 16, 2022
Transactions value $
$185,750
Form type
4
Date filed
11/17/2022, 03:06 PM
Previous filing
Oct 5, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Options Exercise $11.9K +5.15K +2.84% $2.32* 186K Nov 16, 2022 Direct
transaction VERA Class A Common Stock Options Exercise $174K +60K +32.21% $2.90* 246K Nov 16, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (Right to Buy) Options Exercise $0 -5.15K -90.9% $0.00 516 Nov 16, 2022 Class A Common Stock 5.15K $2.32 Direct F1
transaction VERA Stock Option (Right to Buy) Options Exercise $0 -60K -6.33% $0.00 887K Nov 16, 2022 Class A Common Stock 60K $2.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the shares subject to the option vested on January 10, 2021, and 1/36 of the shares vest monthly thereafter.
F2 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter.